These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4135044)

  • 1. [Intrahepatic cholestasis following ovosiston].
    Kraatz G; Linke A
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of dysmenorrhea].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
    Piesbergen H
    Med Welt; 1968 Feb; 9():451-3. PubMed ID: 4181421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
    Böhme HH; Otto HJ
    Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
    Ebeling K; Kühndel K; Rothe K; Canzler E
    Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-induced liver damage following use of the oral contraceptive Femigen].
    Kwaśniewska W; Raczyńska A
    Patol Pol; 1974; 25(1):101-6. PubMed ID: 4133325
    [No Abstract]   [Full Text] [Related]  

  • 7. [Menstruation disorders due to Ovosiston medication].
    Kühndel K; Ebeling K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC; Kaufman RH
    Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of cholestasis in infectious hepatitis].
    Semmler H; Mittmann W; Rosenberg E
    Dtsch Gesundheitsw; 1970 Jul; 25(29):1341-4. PubMed ID: 5509652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cholestatic icterus after intake of ovulation inhibitors].
    Pansold E; Fischer I; Pfeifer K
    Dtsch Gesundheitsw; 1974 Mar; 29(10):470-5. PubMed ID: 4142434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C
    Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coronary infarction associated with ovulation inhibitors].
    Dejaco RM; Hartl O; Pürgyi P
    Wien Med Wochenschr; 1972 Nov; 122(43):630-2. PubMed ID: 4120546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
    Müller R; Kempf HJ; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
    Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
    Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contraceptives, application and side effects from the dermatological viewpoint].
    Schäfer I
    Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in heparinocytes during the administration of Depositon and Sequenz-Ovosiston].
    Frick G; Göretzlehner G
    Zentralbl Gynakol; 1975; 97(8):488-93. PubMed ID: 56830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum enzyme examinations in the climacteric under the treatment with the estrogen-gestagen combination Ovosiston].
    Müller W; Bonow A; Klinger G; Hempel E
    Zentralbl Gynakol; 1969 Jul; 91(27):867-73. PubMed ID: 4188685
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
    Heller H
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1035-8. PubMed ID: 4114489
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
    Roland M; Clyman M; Decker A; Ober WB
    Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.